PA Medical News about Fibromyalgia Electromagnetic Fields Therapeutic Uses

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Use of Antiemetic Agents in Acute Gastroenteritis

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Low-frequency Pulsed Electromagnetic Field Therapy in Fibromyalgia: A Randomized, Double-blind, Sham-controlled Clinical Study
The Clinical Journal of Pain, 09/25/09

Sutbeyaz S et al. – Low–frequency pulsed electromagnetic field (PEMF) therapy might improve function, pain, fatigue, and global status in FM patients.

Methods

56 women with FM, aged 18 to 60 years, were randomly assigned to either PEMF or sham therapy.
Both the PEMF group (n=28) and the sham group (n=28) participated in therapy, 30 minutes per session, twice a day for 3 weeks.
Treatment outcomes were assessed by the fibromyalgia Impact questionnaire (FIQ), visual analog scale (VAS), patient global assessment of response to therapy, Beck Depression Inventory (BDI), and Short–Form 36 health survey (SF–36), after treatment (at 4 wk) and follow–up (at 12 wk).

Results

The PEMF group showed significant improvements in FIQ, VAS pain, BDI score, and SF–36 scale in all domains at the end of therapy.
These improvements in FIQ, VAS pain, and SF–36 pain score during follow–up.
The sham group also showed improvement were maintained on all outcome measures except total FIQ scores after treatment.
At 12 weeks follow–up, only improvements in the BDI and SF–36 scores were present in the sham group.